Insights into the binding mode of new N-substituted pyrazoline derivatives to MAO-A: Docking and quantum chemical calculations

Journal of Neural Transmission

Volumn 120, Issue 6, 2013, Pages 859-862

  Erdem, Safiye Saǧ ^a   Türkkan, Seyhan ^a   Yelekçi, Kemal ^b   Gökhan Kelekçi, Nesrin ^c  

^a MARMARA UNIVERSITY   (Turkey)

^b KADIR HAS UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Docking; N substituted pyrazolines; PM6

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; PYRAZOLINE DERIVATIVE;

ARTICLE; HUMAN; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; QUANTUM CHEMISTRY;

ANIMALS; BINDING SITES; HUMANS; MODELS, MOLECULAR; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PYRAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84878677014     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0950-4     Document Type: Article

References (24)

1. Akyüz M, Erdem SS, Edmondson DE (2007) Aromatic cage in the active site of monoamine oxidase B: effect on the structural and electronic properties of bound benzylamine and p-nitrobenzylamine. J Neural Transm 114:693-698
2. Binda C, Huba'lek F, Li M, DE Edmondson, Mattevi A (2004) Crystal structure of human monoamine oxidase B, a drug target enzyme monotopically inserted into the mitochondrial outer membrane. FEBS Lett 564:225-228
3. Discovery Studio Modeling Environment (2011) Release 3.1. Accelrys Software Inc., San Diego
4. Edmondson DE, Mattevi A, Binda C, Li M, Huba'lek F (2004) Structure and mechanism of monoamine oxidase. Curr Med Chem 11:1983-1993
5. Erdem SS, Büyükmenekşe B (2011) Computational investigation on the structure-activity relationship of the biradical mechanism for monoamine oxidase. J Neural Transm 118:1021-1029
6. Erdem SS, Yelekçi K (2001) Computer modeling of oxygen containing heptylamines as monoamine oxidase inactivators. J Mol Struct Theochem 572:97-106
7. Erdem SS, Karahan Ö, YIldIz I, Yelekçi K (2006) A computational study on the amine-oxidation mechanism of monoamine oxidase: insight into the polar nucleophilic mechanism. Org Biomol Chem 4:646-658
8. Frisch MJ et al (2009) Gaussian 09, Revision A1. Gaussian, Inc., Wallingford CT
9. Gasteiger J, Marsili M (1980) Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges. Tetrahedron 36:3219-3228
10. Gökhan-Kelekçi N, Küpeli E, SalgIn U, Özgen Ö, Uçar G, Yeşilada E, Kendi E, Yeşilada A, Bilgin AA (2007) A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics. Bioorg Med Chem 15:5775-5786
11. Huey R, Morris GM, Olson AJ, Goodsell DS (2007) A semi-empirical free energy force field with charge-based desolvation. J Comput Chem 28:1145-1152
12. Jayaprakash V, Sinha BN, Uçar G, Ercan A (2008) Pyrazoline-based mycobactin analogues as MAO-inhibitors. Bioorg Med Chem Lett 18:6362-6368
13. Li M, Binda C, Mattevi A, Edmondson DE (2006) Functional role of the "aromatic cage" in human monoamine oxidase b: structures and catalytic properties of Tyr435 mutant proteins. Biochemistry 45:4775-4784
14. Michel F, Saner P (1999) Python: a programming language for software integration and development. J Mol Graph Model 17:57-61
15. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olsan AJ (1998) Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J Comp Chem 19:1639-1662
16. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 16:2785-2791
17. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L, Schulten K (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26:1781-1802
18. Rezac J, Fanfrlik J, Salahub D, Hobza P (2009) Semiempirical quantum chemical PM6 method augmented by dispersion and h-bonding correction terms reliably describes various types of noncovalent complexes. J Chem Theory Comput 5:1749-1760
19. Riederer P, Lachenmayer L, Laux G (2004) Clinical applications of MAO inhibitors. Curr Med Chem 11:2033-2043
20. Shih JC (2004) Cloning, after cloning, knock-out mice and physiological functions of MAO A and B. Neurotoxicology 25:21-30
21. Son Y, Ma J, Kondou Y, Yoshimura M, Yamashita E, Tsukihara T (2008) Structure of human monoamine oxidase A at 2.2-A resolution: the control of opening the entry for substrates/inhibitors. Proc Natl Acad Sci USA 105:5739-5744
22. Stewart JJP (2007) Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements. J Mol Mod 13:1173-1213
23. Toprakçi M, Yelekçi K (2005) Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (Ki) of a series of experimentally tested compounds. Bioorg Med Chem Lett 15:4438-4446
24. Yelekçi K, Karahan Ö, ToprakçI M (2007) Docking of novel reversible monoamine oxidase-B inhibitors: efficient prediction of ligand binding sites and estimation of inhibitors thermodynamic properties. J Neural Transm 114:725-732